Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Waters Looking To Douse $48 Mil. Jury Award; Index Composite Flat In Q1

This article was originally published in The Gray Sheet

Executive Summary

Waters Corp. has asked the presiding judge in a federal patent infringement trial to review a $47.5 mil. jury award against the firm. A decision is expected by the end of May

You may also be interested in...



Applied Biosystems v. Micromass

Wilmington, Delaware federal court denies motion by Waters Corp. subsidiaries Micromass UK and Micromass to set aside a $47.5 mil. jury award, reached March 15, related to quadrupole mass spectrometer technology patent infringement (1"The Gray Sheet" April 8, 2002, p. 16). Total awarded damages of $52.6 mil. includes $5.1 mil. in pre-judgement interest...

Cullinan Changes Tracks, Moving Lymphoma Bispecific Into Autoimmune

The company will discontinue its trial of the CD19-directed bispecific CLN-978 in NHL and develop it in inflammatory diseases, where it could have an edge over CAR-Ts.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016393

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel